Snoring has long been a condition brushed aside as a mere nuisance. Ongoing research continues to link snoring to serious health problems, such as high blood pressure, stroke and heart attack, said Theravent, Inc. CEO Matt Williams.
San Jose, California (PRWEB) May 21, 2014
Clinically proven by leading sleep specialists to treat snoring, EPAP Therapy represents a breakthrough in the battle against snoring. It features MicroValve technology, which attaches and covers the nostrils to create pressure during exhalation. EPAP keeps pressure in a person's airway while they sleep, keeping the throat open and significantly reducing and/or eliminating the snoring.
More than 1 million nights of Theravent have been used since mid 2012 to stop snoring and achieve a quieter night's sleep.
"Snoring has long been a condition brushed aside as a mere nuisance. Ongoing research continues to link snoring to serious health problems, such as high blood pressure, stroke and heart attack," said Theravent, Inc. CEO Matt Williams. "We are excited by the strong adoption of Theravent for thousands of snorers and we are driven by the powerful testimonials from bed partners enjoying a quieter night of sleep."
Approximately 40 to 50 million Americans are suffering from snoring. Theravent, an over-the-counter product developed from prescription strength technology, was rigorously tested in three clinical trials. The results, published in Sleep Diagnosis and Therapy, showed that it was effective in reducing and eliminating snoring.
"Snoring is a serious health issue and the value of a good night sleep is relevant to everyone," said Williams. "Delivering a quieter nights sleep is our passion and we’re proud to provide an easy to use and clinically proven option with Theravent."
Thousands of sleep physicians have recommended Theravent and the prescription version of EPAP to treat patients with all ranges of sleep-disordered breathing. To learn more, visit http://www.TheraventSnoring.com or call 1-888-SLP-WELL (1-888-757-9355).
About Theravent, Inc.
Theravent, Inc. is a privately held medical device company dedicated to providing noninvasive medical solutions for people with sleep disordered breathing. Based on its innovative MicroValve technology and patented designs, Theravent, Inc. has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. Theravent, Inc.'s devices work by creating expiratory positive airway pressure (EPAP). The company markets prescription-only Provent® Sleep Apnea Therapy, a discreet, easy-to-use nasal device for the treatment of OSA, and Theravent Snore Therapy, an over-the-counter device for the treatment of primary snoring, in the US. Provent is also available in Australia, New Zealand, Canada, Hong Kong, Singapore and South Africa. For more information, please visit http://www.proventtherapy.com or http://www.theravent.com.